Although patients with HCC having baseline AFP ≥ 400 ng/mL have a poor prognosis [26], no significant difference in PFS between patients with AFP ≥ 400 ng/mL and those with AFP < 400 ng/mL was found in this study; this finding may be considered an appositive result. This evidence concerns the gene AFP and hepatocellular carcinoma.